BOSTON, Dec. 21 /PRNewswire/ -- Allied Minds, a pre-seed investment firm, and UNeMed Corporation, the technology transfer organization for the University of Nebraska Medical Center, have partnered to establish Purtein, a university spinout corporation providing a simpler, more cost effective method for the purification of proteins.
The newly formed Purtein LLC has secured on an exclusive basis novel technology developed by Drs. Elliot Bedows and Jason Wilken of the School of the University of Nebraska College of Medicine. "This technology will offer researchers and pharmaceutical companies a dramatically higher yielding recombinant protein purification process utilizing the binding properties between a wide range of protein molecules," said Dr. Bedows. Additionally, the Purtein technology can be used in virtually every production vehicle: mammalian, microbial, and plant.
This unique technology will reduce both direct costs of chemicals required as well as the indirect costs associated with the greater complexity and time required under current purification processes. Current purification processes represents up to 70 percent of the cost of production. Purtein expects to reduce these production costs dramatically. The preparation of commercial products such as enzymes (e.g. lactase) or nutritional proteins (e.g. soy protein isolates) or certain biopharmaceuticals (e.g. insulin) as well as analytical purification for research purposes will benefit from this technology.
"We are fortunate to be teaming with UNeMed and this outstanding scientific team to bring what we believe will be the next generation of purification technology to the marketplace," said Allied Minds CEO Christopher Silva.
Dr. James Linder, President of UNeMed Corporation further added that, "We are very excited about this new agreement between UNeMed Corporation and Allied Minds. We see it as a fast, effective way to commercialize this novel technology."
About Allied Minds, Inc.
Allied Minds is a pre-seed investment company creating partnerships with key Universities to fund corporate spinouts resulting from successful early stage technology research. By providing corporate development support as well as finance, Allied Minds aims to guide early stage companies to commercial success, thereby generating value for all stakeholders. For additional information, logon to http://www.alliedminds.com.
Allied Minds, Inc.CONTACT: Chris Silva, CEO, of Allied Minds, +1-781-353-6404, orchris.silva@alliedminds.com
Web site: http://www.alliedminds.com/
